RDY
Dr. Reddy's Laboratories Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IN
$14.68
+2.62%Leverage
- Debt / equity
- 0.19x
- Net debt / equity
- 0.15x
- Debt / assets
- 0.13x
- Debt / EBITDA
- 1.35x
- Net debt / EBITDA
- 1.10x
Liquidity & coverage
- Current ratio
- 1.93x
- Quick ratio
- 1.40x
- Cash ratio
- 0.49x
- Interest coverage
- 6.52x
- EBITDA / interest
- 11.90x
- Working capital
- $1.5B
Cash & dividend
- FCF / debt
- 0.17x
- Cash flow / debt
- 0.41x
- Dividend per share
- $0.15
- Dividend yield
- 1.0%
- Dividend growth 1y
- +61.4%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026